GW Pharmaceuticals Plc
(NASDAQ : GWPH)

( )
GWPH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.33%57.236.5%$169.22m
CTLTCatalent, Inc. -1.45%78.002.4%$132.70m
VRXValeant Pharmaceuticals International, Inc. 0.29%17.2014.1%$101.21m
JAZZJazz Pharmaceuticals Plc 1.08%106.602.4%$81.66m
UTHRUnited Therapeutics Corp. 0.45%117.4414.3%$68.96m
BHCBausch Health Cos., Inc. 0.29%17.200.0%$68.81m
ICPTIntercept Pharmaceuticals, Inc. 2.80%45.0916.8%$63.68m
PCRXPacira Biosciences, Inc. 0.49%57.8010.3%$55.61m
AXSMAxsome Therapeutics, Inc. 1.37%83.041.9%$51.78m
ZGNXZogenix, Inc. -2.05%27.247.5%$47.44m
PRGOPerrigo Co. Plc 1.68%55.176.8%$45.82m
MYOKMyoKardia, Inc. -0.29%92.861.8%$45.18m
ARGXargenx SE -1.04%250.510.0%$42.94m
GWPHGW Pharmaceuticals Plc -0.16%127.906.2%$38.07m
ICLRICON plc -2.48%169.964.3%$37.43m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.